Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL742146

Cc1c(S(=O)(=O)n2cc3c4c(cccc42)CNCC3)sc2ccc(Cl)cc12.O=C(O)C(F)(F)F

nearest known ligand 0.49

Full drug profile on Sugi Atlas →

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
HTR6 P50406 13/20 0.49
SLC2A1 P11166 1/20 0.40
PFKFB4 Q16877 4/20 0.40
PFKFB3 Q16875 4/20 0.40
CYP3A4 P08684 1/20 0.35
HTR1A P08908 2/20 0.35
HTR1D P28221 2/20 0.35
HTR1B P28222 2/20 0.35
HTR2C P28335 2/20 0.35
DRD2 P14416 1/20 0.35
DRD1 P21728 1/20 0.35
DRD4 P21917 1/20 0.35
HTR2A P28223 1/20 0.35
HTR7 P34969 1/20 0.35
ADRA1B P35368 1/20 0.35
DRD3 P35462 1/20 0.35
HTR4 Q13639 1/20 0.35
CMA1 P23946 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL742627 0.93 HTR6 (0.56) HTR6SLC2A1PFKFB4PFKFB3CYP3A4
Trifluoroacetic Acid SCHEMBL741153 0.81 HTR6 (0.52) HTR6CYP3A4HTR2CHTR2A
Trifluoroacetic Acid SCHEMBL743994 0.81 HTR6 (0.46) HTR6CYP3A4HTR2CHTR2A
Trifluoroacetic Acid SCHEMBL741125 0.80 SPR (0.33) HTR6HTR2C
Trifluoroacetic Acid SCHEMBL743160 0.79 HTR2C (0.40) HTR6CYP3A4HTR2CHTR2ADRD3
Trifluoroacetic Acid SCHEMBL743482 0.79 HTR6 (0.34) HTR6CYP3A4HTR2CHTR2A
Trifluoroacetic Acid SCHEMBL744550 0.79 HTR6 (0.39) HTR6CYP3A4HTR2CHTR2A
Trifluoroacetic Acid SCHEMBL744465 0.78 HTR6 (0.46) HTR6CYP3A4HTR2CHTR2A
Trifluoroacetic Acid SCHEMBL741198 0.78 HTR6 (0.36) HTR6CYP3A4HTR2CHTR2ADRD3
Trifluoroacetic Acid SCHEMBL743912 0.77 HTR6 (0.46) HTR6CYP3A4HTR1DHTR1BHTR2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8138333-B2 Sulfonyl-indole derivatives PROXIMAGEN LIMITED (GB) 2012-03-20 US disclosed
US-20080293694-A1 New compounds BIOVITRUM AB (PUBL.) (SE) 2008-11-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080293694-A1 New compounds HTR6, HTR1A, HTR1B HTR6 1/4885SLC2A1 1589/4885PFKFB4 1779/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.